About this episode
The episode discusses the potential of marijuana in treating anxiety and chronic pain, highlighting the need for rigorous scientific research.
For years we've been told marijuana can treat everything from anxiety to chronic pain, often with more confidence than evidence because cannabis as an illegal drug is so hard to study. Now, the U.S. is reclassifying cannabis in a way that could finally make real scientific research easier. It's moving from a Schedule I drug, alongside heroin, to Schedule III, closer to drugs like Tylenol with codeine. That change could open the door to much more real research. Dr. Margaret Haney is a neurobiology professor at Columbia University and runs its Cannabis Research Lab. For decades, she's argued marijuana has been sold as medicine without the kind of rigorous testing every other prescription drug is required to go through. Even with the limitations, her work has shown the dangers of cannabis use disorder and the impacts weed can have on the teenage brain.
People in this episode
Guest: Dr. Margaret Haney
Topics covered
- marijuana
- anxiety
- chronic pain
- cannabis research
- drug classification
- cannabis use disorder
Keywords
- marijuana
- anxiety
- chronic pain
- cannabis research
- drug classification
- cannabis use disorder
- teenage brain
Mentioned in this episode
Organizations: Columbia University
Products: Tylenol with codeine
Places: U.S., Schedule I, Schedule III, teenage brain
More episodes of Afternoons
- Critter of the Week: Orange Coral Fungus · June 12, 2026 · 16 min
- Weekend Stuff: Building a Deck · June 12, 2026 · 10 min
- Food: Spiced Chicken and Rice · June 12, 2026 · 5 min
- At The Movies for 12 June 2026 · June 12, 2026 · 12 min
- Freaky Friday: The unexplained and unusual · June 12, 2026 · 5 min
- What impact do international film productions have on tourism? · June 12, 2026 · 13 min
Explore listener stats, chart rankings, contacts and more on the Afternoons podcast page.